Transcriptomic Approach to Lesch-Nyhan Disease

Lesch-Nyhan disease (LND) is an X-linked metabolic disease caused by various mutations in the gene HPRT1 encoding an enzyme of purine metabolism, hypoxanthine guanine phosphoribosyltransferase (HPRT). In its most severe form, LND patients suffer from overproduction of uric acid along with neurological or behavioural difficulties including self-injurious behaviours. To gain more insight into pathogenesis, we compared the transcriptome from human LND fibroblasts to normal human fibroblasts using a microarray with 60,000 probes corresponding to the entire human genome. Using stringent criteria, we identified 25 transcripts whose expression was significantly different between LND and control cells. These genes were confirmed by quantitative RT-PCR to be dysregulated in LND cells. Moreover, bioinformatic analysis of microarray data using gene ontology (GO) highlighted clusters of genes displaying biological processes most significantly affected in LND cells. These affected genes belonged to specific processes such as cell cycle and cell-division processes, metabolic and nucleic acid processes, demonstrating the specific nature of the changes and providing new insights into LND pathogenesis.

[1]  William C Earnshaw,et al.  Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. , 2004, The Journal of cell biology.

[2]  T. Friedmann,et al.  Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  J. Neary,et al.  Trophic functions of nucleotides in the central nervous system , 2009, Trends in Neurosciences.

[4]  H. Jinnah Lesch–Nyhan Disease and Its Variants , 2016 .

[5]  William C Hahn,et al.  The Cdk1 complex plays a prime role in regulating N-myc phosphorylation and turnover in neural precursors. , 2005, Developmental cell.

[6]  S. Mishra,et al.  Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation , 2006, Development.

[7]  William,et al.  The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs, B., Kinzler, K. W., and Vogelstein, B., eds., 8th ed., McGraw-Hill, New-York, 2001, 7012 p., $550.00) , 2004, Biochemistry (Moscow).

[8]  T. Friedmann,et al.  Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  R. Roberts,et al.  Basal ganglia dopamine loss due to defect in purine recycling , 2007, Neurobiology of Disease.

[10]  D. Sutcliffe,et al.  Purine metabolism during neuronal differentiation: the relevance of purine synthesis and recycling , 2013, Journal of neurochemistry.

[11]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[12]  Madhuri Hegde,et al.  Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. , 2014, Brain : a journal of neurology.

[13]  P. Rakic,et al.  The role of ATP signaling in the migration of intermediate neuronal progenitors to the neocortical subventricular zone , 2008, Proceedings of the National Academy of Sciences.

[14]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[15]  Theodore Friedmann,et al.  Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase , 2012, Proceedings of the National Academy of Sciences.

[16]  Theodore Friedmann,et al.  HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene? , 2011, PloS one.

[17]  L. Dauphinot,et al.  Hypoxanthine-guanine phosphoribosyl transferase regulates early developmental programming of dopamine neurons: implications for Lesch-Nyhan disease pathogenesis. , 2009, Human molecular genetics.

[18]  Alan C. Evans,et al.  Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Schretlen,et al.  Mechanisms for phenotypic variation in Lesch–Nyhan disease and its variants , 2010, Human Genetics.

[20]  I. Ceballos-Picot,et al.  Clinical utility gene card for: Lesch–Nyhan Syndrome - update 2013 , 2013, European Journal of Human Genetics.

[21]  W. Nyhan,et al.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. , 1964, The American journal of medicine.

[22]  N. Philip,et al.  Kelley–Seegmiller syndrome due to a new variant of the hypoxanthine–guanine phosphoribosyltransferase (I136T) encoding gene (HPRT Marseille) , 2004, Journal of Inherited Metabolic Disease.

[23]  B. Bloem,et al.  Delineation of the motor disorder of Lesch-Nyhan disease. , 2006, Brain : a journal of neurology.

[24]  G. Invernici,et al.  Human neural stem cells: a model system for the study of Lesch-Nyhan disease neurological aspects. , 2010, Human molecular genetics.

[25]  H. Jinnah,et al.  Severe gouty arthritis and mild neurologic symptoms due to F199C, a newly identified variant of the hypoxanthine guanine phosphoribosyltransferase. , 2009, Arthritis and rheumatism.

[26]  Esther B. E. Becker,et al.  Activation of FOXO1 by Cdk1 in Cycling Cells and Postmitotic Neurons , 2008, Science.

[27]  M. Ernst,et al.  Presynaptic dopaminergic deficits in Lesch-Nyhan disease. , 1996, The New England journal of medicine.

[28]  R. Torres,et al.  Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome , 2007, Orphanet journal of rare diseases.

[29]  W. Halliday,et al.  Multifocal Atrophy of Cerebellar Internal Granular Neurons in Lesch-Nyhan Disease: Case Reports and Review , 2007, Journal of neuropathology and experimental neurology.

[30]  H. Jinnah,et al.  Consequences of impaired purine recycling in dopaminergic neurons , 2008, Neuroscience.

[31]  G. Guibinga,et al.  HPRT-Deficiency Dysregulates cAMP-PKA Signaling and Phosphodiesterase 10A Expression: Mechanistic Insight and Potential Target for Lesch-Nyhan Disease? , 2013, PloS one.

[32]  G. Burnstock Purinergic signalling and disorders of the central nervous system , 2008, Nature Reviews Drug Discovery.